balance equationinconsistent2020-12-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
Revenue
$605.49M
Fiscal year ended 2025-12-31Operating income
$108.58M
Fiscal year ended 2025-12-31Free cash flow
$133.59M
Fiscal year ended 2025-12-31TransMedics Group, Inc. (TMDX) reported revenue of $605.49M and net income of $190.29M for the fiscal year ended 2025-12-31. This page shows 8 annual periods of income statement, balance sheet and cash flow figures normalized from TransMedics Group, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-28 | 2018-12-29 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $605.49M | $441.54M | $241.62M | $93.46M | $30.26M | Unavailable | $23.60M | $13.02M |
| Cost of revenue | $242.69M | $179.46M | $87.53M | $28.19M | $9.10M | Unavailable | $9.74M | $7.28M |
| Gross profit | $362.81M | $262.08M | $154.09M | $65.27M | $21.16M | Unavailable | $13.86M | $5.73M |
| Operating income | $108.58M | $37.50M | -$28.73M | -$31.44M | -$39.43M | Unavailable | -$29.60M | -$20.24M |
| Net income | $190.29M | $35.46M | -$25.03M | -$36.23M | -$44.22M | Unavailable | -$33.55M | -$23.76M |
| Research & development | $69.06M | $55.97M | $36.06M | $26.81M | $22.30M | Unavailable | $19.87M | $13.66M |
| Weighted-average diluted shares | shares 40.54M | shares 35.22M | shares 32.52M | shares 29.56M | shares 27.62M | Unavailable | Unavailable | Unavailable |
| Pretax income | $107.52M | $35.78M | -$26.67M | -$36.16M | -$44.18M | Unavailable | -$33.51M | -$23.72M |
| Income tax expense | -$82.77M | $316.00K | -$1.64M | $66.00K | Unavailable | Unavailable | $0 | $0 |
| Diluted EPS | $4.87 | $1.01 | $-0.77 | $-1.23 | $-1.60 | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | $185.17M | $168.62M | $119.55M | $69.90M | $38.28M | Unavailable | $23.60M | $12.32M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-28 | 2018-12-29 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | $394.81M | $201.18M | $25.58M | Unavailable | $20.09M | $20.24M |
| Total assets | $1.07B | $804.08M | $706.05M | $277.15M | $134.89M | Unavailable | $105.30M | $42.16M |
| Current assets | $637.78M | $497.22M | $510.65M | $252.29M | $118.70M | Unavailable | $100.00M | $34.79M |
| Total liabilities | $595.27M | $575.47M | $568.84M | $89.77M | $67.04M | Unavailable | $50.65M | $47.88M |
| Current liabilities | $89.30M | $59.91M | $54.93M | $23.66M | $23.24M | Unavailable | $16.12M | $12.55M |
| Total equity incl. NCI | $473.10M | $228.60M | $137.20M | $187.38M | $67.85M | Unavailable | $54.65M | -$192.24M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $186.52M |
| Inventory | $48.88M | $46.55M | $44.24M | $20.60M | $14.86M | Unavailable | $11.22M | $9.28M |
| Accounts receivable | $84.28M | $97.72M | $63.58M | $27.61M | $5.93M | Unavailable | $6.56M | $3.44M |
| Goodwill | $11.55M | $11.55M | $11.99M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | $58.70M | $35.20M | Unavailable | $34.15M | $33.67M |
| Accounts payable | $10.35M | $10.29M | $12.72M | $3.34M | $6.65M | Unavailable | $7.25M | $4.72M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-28 | 2018-12-29 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $192.84M | $48.80M | -$13.03M | -$45.82M | -$28.86M | Unavailable | -$32.29M | -$25.98M |
| Capital expenditures | $59.25M | $129.74M | $151.85M | $11.91M | $3.52M | Unavailable | $165.00K | $418.00K |
| Investing cash flow | -$59.25M | -$129.30M | -$193.95M | $54.51M | $29.27M | Unavailable | -$60.50M | $12.31M |
| Financing cash flow | $16.86M | $22.87M | $400.42M | $167.93M | $1.39M | Unavailable | $92.72M | $22.06M |
| Net change in cash | $151.72M | -$58.16M | $193.63M | $175.60M | $999.00K | Unavailable | -$149.00K | $8.30M |
| Stock-based compensation | $36.86M | $33.22M | $19.79M | $10.32M | $6.88M | Unavailable | $854.00K | $144.00K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $27.18M | $19.76M | $8.18M | $3.48M | $1.82M | Unavailable | $1.22M | $769.00K |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-28 | 2018-12-29 |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $133.59M | -$80.94M | -$164.88M | -$57.72M | -$32.38M | Unavailable | -$32.45M | -$26.40M |
| Gross margin | 59.9% | 59.4% | 63.8% | 69.8% | 69.9% | Unavailable | 58.7% | 44.1% |
| Operating margin | 17.9% | 8.5% | -11.9% | -33.6% | -130.3% | Unavailable | -125.4% | -155.5% |
| FCF margin | 22.1% | -18.3% | -68.2% | -61.8% | -107.0% | Unavailable | -137.5% | -202.8% |
| SBC / revenue | 6.1% | 7.5% | 8.2% | 11.0% | 22.7% | Unavailable | 3.6% | 1.1% |
| Current ratio | 7.14x | 8.30x | 9.30x | 10.66x | 5.11x | Unavailable | 6.21x | 2.77x |
| Revenue YoY growth | 37.1% | 82.7% | 158.5% | 208.8% | Unavailable | Unavailable | 81.3% | Unavailable |
| Net margin | 31.4% | 8.0% | -10.4% | -38.8% | -146.1% | Unavailable | -142.1% | -182.5% |
| R&D / revenue | 11.4% | 12.7% | 14.9% | 28.7% | 73.7% | Unavailable | 84.2% | 104.9% |
| CapEx / revenue | 9.8% | 29.4% | 62.8% | 12.7% | 11.6% | Unavailable | 0.7% | 3.2% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | -77.0% | 0.9% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TMDX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2020-12-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.